This randomized , single-blinded , positive and placebo-controlled , parallel-group , multiple-dose bioactivity study was conducted to assess the potential of a new beclomethasone dipropionate 84 microg double-strength metered-dose inhaler ( Vanceril 84 microg Double Strength Inhalation Aerosol/Key ) to cause hypothalamic-pituitary-adrenocortical axis suppression .
